FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise
February 11, 2026 2 min read Add Us On GoogleAdd SciAm FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise The U.S.’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots By Jackie Flynn Mogensen edited by Claire Cameron An…
